Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec2cf2772a722c89d7cdeaf3f7f441cc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-002 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate |
2015-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf99cb20a33f55f762c9408043a9428a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6f4aa7ecbbcfa6a4d36273bb4856c17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4c9c736988c6d8790cc7ecede236ebc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cef1137289cc39e69f68982c431d7189 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92ae5678c8639f37ba5a63203be70047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_780c55c4f0ea6bf657b5d142549241be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77e211c5ae2b8be4bf75f90755a31421 |
publicationDate |
2019-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10301367-B2 |
titleOfInvention |
Compositions and methods for treatment of muscular dystrophy |
abstract |
The present invention features modified human transcription factors capable of increasing utrophin expression, recombinant adeno-associated vectors for delivery of the modified human transcription factors, and methods of treating muscle diseases, including Duchenne's muscular dystrophy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10780149-B2 |
priorityDate |
2014-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |